1. Home
  2. PRM vs EWTX Comparison

PRM vs EWTX Comparison

Compare PRM & EWTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PRM
  • EWTX
  • Stock Information
  • Founded
  • PRM 2018
  • EWTX 2017
  • Country
  • PRM United States
  • EWTX United States
  • Employees
  • PRM N/A
  • EWTX 117
  • Industry
  • PRM Newspapers/Magazines
  • EWTX Biotechnology: Pharmaceutical Preparations
  • Sector
  • PRM Consumer Discretionary
  • EWTX Health Care
  • Exchange
  • PRM Nasdaq
  • EWTX Nasdaq
  • Market Cap
  • PRM 1.5B
  • EWTX 1.5B
  • IPO Year
  • PRM N/A
  • EWTX 2021
  • Fundamental
  • Price
  • PRM $15.26
  • EWTX $13.01
  • Analyst Decision
  • PRM Strong Buy
  • EWTX Buy
  • Analyst Count
  • PRM 2
  • EWTX 9
  • Target Price
  • PRM $15.50
  • EWTX $39.89
  • AVG Volume (30 Days)
  • PRM 1.1M
  • EWTX 936.5K
  • Earning Date
  • PRM 07-31-2025
  • EWTX 08-07-2025
  • Dividend Yield
  • PRM N/A
  • EWTX N/A
  • EPS Growth
  • PRM N/A
  • EWTX N/A
  • EPS
  • PRM 0.90
  • EWTX N/A
  • Revenue
  • PRM $573,954,000.00
  • EWTX N/A
  • Revenue This Year
  • PRM N/A
  • EWTX N/A
  • Revenue Next Year
  • PRM $5.12
  • EWTX N/A
  • P/E Ratio
  • PRM $16.99
  • EWTX N/A
  • Revenue Growth
  • PRM 70.16
  • EWTX N/A
  • 52 Week Low
  • PRM $7.49
  • EWTX $10.60
  • 52 Week High
  • PRM $15.33
  • EWTX $38.12
  • Technical
  • Relative Strength Index (RSI)
  • PRM 82.66
  • EWTX 35.24
  • Support Level
  • PRM $13.79
  • EWTX $12.72
  • Resistance Level
  • PRM $14.30
  • EWTX $13.84
  • Average True Range (ATR)
  • PRM 0.43
  • EWTX 0.67
  • MACD
  • PRM 0.07
  • EWTX -0.18
  • Stochastic Oscillator
  • PRM 96.94
  • EWTX 24.36

About PRM Perimeter Solutions SA

Perimeter Solutions Inc is a solutions provider for the Fire Safety and Specialty Products industries. The Company's products and operations are managed and reported in two operating segments. Its Fire Safety segment provides fire retardants and firefighting foams, as well as specialized equipment and services typically offered in conjunction with the Company's retardant and foam products. The Specialty Products segment includes operations that develop, produce and market products for non-fire safety markets. Specialty Products segment is Phosphorus Pentasulfide (P2S5) based lubricant additives. P2S5 is also used in pesticide and mining chemicals applications, and emerging electric battery technologies.

About EWTX Edgewise Therapeutics Inc.

Edgewise Therapeutics Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of treatments for severe, rare muscle disorders. It is developing orally bioavailable, small molecule therapies for musculoskeletal diseases. The company's product candidates are Sevasemten and EDG-7500. Sevasemten is an orally administered small molecule designed to address the root cause of dystrophinopathies including Duchenne muscular dystrophy (Duchenne) and Becker muscular dystrophy (Becker). The company is currently studying Sevasemten in Phase 2 trials, which are being held in the U.S. and Israel and in certain countries in Europe and Australasia.

Share on Social Networks: